ZONEONE PHARMA, INC.

Basic Information

QB3, 1700 4TH STREET
STE 214
SAN FRANCISCO, CA, 94158-

Company Profile

n/a

Additional Details

Field Value
DUNS: 968317870
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload

    Amount: $160,664.00

    DESCRIPTION (provided by applicant): About 100,000 babies are born each year with severe thalassemia type blood disorders or sickle cell anemia, leading to a lifelong regime of blood transfusions. How ...

    SBIR Phase I 2013 Department of Health and Human Services
  2. OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)

    Amount: $215,999.00

    The Hsp90 inhibitor 17-DMAG will be encapsulated in a nano-sized liposome formulation that is long-circulating with controlled drug release properties in tumor tissue. Reformulation of 17-DMAG in a na ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government